On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction

Proceedings of the Society for Experimental Biology and Medicine

Volumn 222, Issue 3, 1999, Pages 196-204

  Frei, Balz ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CELL ADHESION MOLECULE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG MECHANISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; SMOKING; VASCULAR DISEASE;

EID: 0032724347     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.1999.d01-136.x     Document Type: Conference Paper

References (106)

1. American Heart Association. 1999 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 1998.
2. Schwartz CJ, Valente AJ. The pathogenesis of atherosclerosis. In: Frei B, Ed. Natural Antioxidants in Human Health and Disease. San Diego: Academic Press, pp287-302, 1994.
3. Ross R. Rous-Whipple Award Lecture. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 143:987-1002, 1993.
4. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr., Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68, 1995.
5. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344:254-257, 1990.
6. Clinton S, Underwood R, Sherman M, Kufe D, Libby P. Macrophage colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Path 140:301-316, 1992.
7. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791, 1991.
8. Li H, Cybulsky MI, Gimbrone MA Jr., Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb Vasc Biol 13:197-204, 1993.
9. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945-951, 1993.
10. Duplaa C, Couffinhal T, Labat L, Moreau C, Petit-Jean ME, Doutre MS, Lamaziere JM, Bonnet J. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis 121:253-266, 1996.
11. Schwartz D, Andalibi A, Chaverri-Almada L, Berliner JA, Kirchgessner T, Fang ZT, Tekamp-Olson P, Lusis AJ, Gallegos C, Fogelman AM et al. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest 94: 1968-1973, 1994.
12. Shih PT, Elices MJ, Fang ZT, Ugarova TP, Strahl D, Territo MC, Frank JS, Kovach NL, Cabanas C, Berliner JA, Vora DK. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating β1-integrin. J Clin Invest 103:613-625, 1999.
13. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989.
14. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13:341-390, 1992.
15. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis 141:1-15, 1998.
16. McCall MR, Frei B. Mechanism(s) of LDL oxidation. In: Keaney JF Jr., Ed. Oxidative Stress and Vascular Disease. Norwell, MA: Kluwer Academic Press, in press.
17. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76:333-337, 1979.
18. Henriksen T, Mahoney EM, Steinberg D. Enhanced macrophage degradation of low-density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low-density lipoproteins. Proc Natl Acad Sci U S A 78:6499-6503, 1981.
19. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94:437-444, 1994.
20. Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 97:1535-1544, 1996.
21. Hazell LJ, Stocker R. α-Tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein. FEBS Lett 414:541-544, 1997.
22. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, et al. Monocyte transmigration induced by modification of low-density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein-1 synthesis and is abolished by high-density lipoprotein. J Clin Invest 88:2039-2046, 1991.
23. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein receptor-deficient mice. Mol Cell 2:275-281, 1998.
24. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773-778, 1999.
25. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low-density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85:1260-1266, 1990.
26. Frostegard J, Haegerstrand A, Gidlund M, Nilsson J. Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 90:119-126, 1991.
27. Lehr HA, Hubner C, Finckh B, Angermuller S, Nolte D, Beisiegel U, Kohlschutter A, Messmer K. Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low-density lipoprotein in hamsters. J Clin Invest 88:9-14, 1991.
28. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, Smith CW, Haberland ME, Fogelman AM, Berliner JA. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb Vasc Biol 14:427-433, 1994.
29. Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: Role of protein kinase C. Circ Res 74:565-575, 1994.
30. Cominacini L, Garbin U, Pasini AF, Davoli A, Campagnola M, Contessi GB, Pastorino AM, Lo Cascio V. Antioxidants inhibit the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radic Biol Med 22:117-127, 1997.
31. Vora DK, Fang ZT, Liva SM, Tyner TR, Parhami F, Watson AD, Drake TA, Territo MC, Berliner JA. Induction of P-selectin by oxidized lipoproteins: Separate effects on synthesis and surface expression. Circ Res 80:810-818, 1997.
32. Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 337:408-416, 1997.
33. Stocker R, Frei B. Endogenous antioxidant defenses in human blood plasma. In: Sies H, Ed. Oxidative Stress: Oxidants and Antioxidants. London: Academic Press, pp213-243, 1991.
34. Jones DP, Carlson JL, Samiec PS, Sternberg P Jr, Mody VC Jr., Reed RL, Brown LA. Glutathione measurement in human plasma: Evaluation of sample collection, storage, and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 275:175-184, 1998.
35. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 53:314S-321S, 1991.
36. 2-isoprostanes) in plasma and low-density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 93:998-1004, 1994.
37. Gokce N, Frei B. Basic research in antioxidant inhibition of steps in atherogenesis. J Cardiovasc Risk 3:352-357, 1996.
38. McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 26:1034-1053, 1999.
39. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 85:9748-9752, 1988.
40. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma: Protective effects of ascorbic acid. Biochem J 277:133-138, 1991.
41. Frei B, Stocker R, Ames BN. Small molecule antioxidant defenses in human extracellular fluids. In: Scandalios J, Ed. The Molecular Biology of Free Radical Scavenging Systems. Cold Spring Harbor, NY: CSH Laboratory Press, pp23-45, 1992.
42. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 86:6377-6381, 1989.
43. Berger TM, Polidori MC, Dabbagh A, Evans PJ, Halliwell B, Morrow JD, Roberts LJ II, Frei B. Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem 272:15656-15660, 1997.
44. Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product (s) protect human low-density lipoprotein against atherogenic modification: Anti- rather than pro-oxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 268:1304-1309, 1993.
45. Retsky KL, Frei B. Vitamin C prevents metal ion-dependant initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim Biophys Acta 1257:279-287, 1995.
46. Hatta A, Frei B. Oxidative modification and antioxidant protection of human low-density lipoprotein at high and low oxygen partial pressures. J Lipid Res 36:2383-2393, 1995.
47. Retsky KL, Chen K, Zeind J, Frei B. Inhibition of copper-induced LDL oxidation by vitamin C is associated with decreased copper binding to LDL and 2-oxo-histidine formation. Free Radic Biol Med 26:90-98, 1999.
48. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci U S A 88:1646-1650, 1991.
49. Martin A, Frei B. Both intra- and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol 17:1583-1590, 1997.
50. Lynch SM, Gaziano MJ, Frei B. Ascorbic acid and atherosclerotic cardiovascular disease. In: Harris JR, Ed. Ascorbic Acid: Biochemistry and Biomedical Cell Biology. New York: Plenum Press, pp331-367, 1996.
51. Gaziano MJ, Hatta A, Flynn M, Johnson EJ, Krinsky NI, Ridker PM, Hennekens CH, Frei B. Supplementation with β-carotene in vivo and in vitro does not inhibit low-density lipoprotein oxidation. Atherosclerosis 112:187-195, 1995.
52. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation: A dose-response study. Arterioscler Thromb Vasc Biol 15:190-197, 1995.
53. Simons LA, Von Konigsmark M, Balasubramaniam S. What dose of vitamin E is required to reduce susceptibility of LDL to oxidation? Aust N Z J Med 26:496-503, 1996.
54. Princen HMG, van Duyvenvoorde W, Buytenhek R, van der Laarse A, van Poppel G, Gevers Leuven JA, van Hinsbergh VWM. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 15:325-333, 1995.
55. Bowry VW, Stocker R. Tocopherol-mediated peroxidation: The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 115:6029-6040, 1993.
56. Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low-density lipoprotein: Use of a new water-soluble probucol derivative. J Clin Invest 89:1618-1621, 1992.
57. Islam KN, Devaraj S, Jialal I. α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 98:2255-2261, 1998.
58. Devaraj S, Jialal I. α-Tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler Thromb Vasc Biol 19:1125-1133, 1999.
59. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92:1866-1874, 1993.
60. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993.
61. Weber C, Erl W, Pietsch A, Strobel M, Ziegler-Heitbrock HW, Weber PC. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. Arterioscler Thromb Vasc Biol 14:1665-1673, 1994.
62. Faruqi R, de la Motte C, DiCorleto PE. α-Tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 94:592-600, 1994.
63. Faruqi RM, Poptic EJ, Faruqi TR, de la Motte C, DiCorleto PE. Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression. Am J Physiol 273: H817-H826, 1997.
64. Martin WJI. Neutrophils kill pulmonary endothelial cells by a hydrogen peroxide-dependent pathway. Am Rev Respir Dis 130:209-213, 1984.
65. Jonas E, Dwenger A, Hager A. In vitro effect of ascorbic acid on neutrophil-endothelial cell interaction. J Biolumin Chemilumin 8:15-20, 1993.
66. Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci U S A 91:7688-7692, 1994.
67. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 91:1525-1532, 1995.
68. Weber C, Wolfgang E, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93:1488-1492, 1996.
69. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 71:380-386, 1994.
70. Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral 1-arginine but not vitamin C. J Am Coll Cardiol 29:491-497, 1997.
71. Negre-Salvayre A, Alomar Y, Troly M, Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways. Biochim Biophys Acta 1096:291-300, 1991.
72. Reid VC, Mitchinson MJ. Toxicity of oxidised low-density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis 98:17-24, 1993.
73. Suttorp N, Toepfer W, Roka L. Antioxidant defense mechanisms of endothelial cells: Glutathione redox cycle versus catalase. Am J Physiol 251:C671-C680, 1986.
74. Andreoli SP, Mallett CP, Bergstein JM. Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury. J Lab Clin Med 108:190-198, 1986.
75. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Protective role of intracellular glutathione against oxidized low-density lipoprotein in cultured endothelial cells. Biochem Biophys Res Commun 163:1466-1472, 1989.
76. Thomas JP, Geiger PG, Girotti AW. Lethal damage to endothelial cells by oxidized low-density lipoprotein: Role of selenoperoxidases in cytoprotection against lipid hydroperoxide- and iron-mediated reactions. J Lipid Res 34:479-490, 1993.
77. Kaneko T, Kaji K, Matsuo M. Protective effect of lipophilic derivatives of ascorbic acid on lipid peroxide-induced endothelial injury. Arch Biochem Biophys 304:176-180, 1993.
78. Cooke JP, Dzau VJ. Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 48:489-509, 1997.
79. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454-456, 1986.
80. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551, 1993.
81. Myers PR, Wright TF, Tanner MA, Ostlund RE Jr. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium. J Lab Clin Med 124:672-683, 1994.
82. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344:160-162, 1990.
83. Levine GL, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93:1107-1113, 1996.
84. Gokce N, Keaney JF Jr., Frei B, Holbrook M, Olesiak M, Zachariah BJ, Leeuwenburgh C, Heinecke JW, Vita JA. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99:3234-3240, 1999.
85. Ito K, Akita H, Kanazawa K, Yamada S, Terashima M, Matsuda Y, Yokoyama M. Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease. Am J Cardiol 82:762-767, 1998.
86. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, Kawano H, Miyao Y, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Yasue H. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 32:103-109, 1998.
87. Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97:363-368, 1998.
88. Ting HH, Timimi FK, Haley EA, Roddy M, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95:2617-2622, 1997.
89. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96:1513-1519, 1997.
90. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222-2229, 1998.
91. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy. Circulation 99:1156-1160, 1999.
92. Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94:6-9, 1996.
93. Motoyama T, Kawano H, Kugiyama K et al. Endothelium-dependent vasodilation in the brachial artery is impaired in smokers: Effect of vitamin C. Am J Physiol 273:H1644-H1650, 1997.
94. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22-28, 1996.
95. Timimi FK, Ting HH, Haley EA, Roddy M, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31:552-557, 1998.
96. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 278:1682-1686, 1997.
97. Green D, O'Driscoll G, Rankin JM, Maiorana AJ, Taylor RR. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin Sci (Colch) 95:361-367, 1998.
98. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y, Miyao Y, Yoshimura M, Ogawa H, Yasue H. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 32:1672-1679, 1998.
99. Heitzer T, Yla Herttuala S, Wild E, Luoma J, Drexler H. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking, or both. J Am Coll Cardiol 33:499-505, 1999.
100. Simons LA, von Konigsmark M, Simons J, Stocker R, Celermajer DS. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 143:193-199, 1999.
101. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83:916-922, 1998.
102. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 93:3704-3709, 1996.
103. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 269:9397-9400, 1994.
104. Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF. L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J Clin Invest 101:1408-1414, 1998.
105. Gorren AC, Schrammel A, Schmidt K, Mayer B. Thiols and neuronal nitric oxide synthase: Complex formation, competitive inhibition, and enzyme stabilization. Biochemistry 36:4360-4366, 1997.
106. Heller R, Munscher-Paulig F, Grabner R, Till U. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274:8254-8260, 1999.